产业年收入超60亿元，合成生物制造企业在昌平打磨“手术刀”

Core Insights - The article highlights the advancements in synthetic biology, particularly through gene editing technologies, which are revolutionizing the production of valuable metabolites and agricultural products, significantly impacting industries such as medicine and agriculture [1][2][5]. Group 1: Synthetic Biology and Gene Editing - The use of genetically engineered yeast to produce artemisinin has demonstrated the potential to replace the extraction from 50,000 acres of Artemisia annua cultivation, benefiting millions of malaria patients in developing countries since 2013 [1]. - Beijing Qihe Biotechnology Co., a representative company in the synthetic biology sector, has achieved a significant increase in oil content in soybeans from over 20% to above 80% through precise gene editing [2]. - The gene editing technology allows for rapid breeding cycles, reducing the time needed to develop disease-resistant traits in crops like wheat from decades to approximately three months [2][3]. Group 2: Innovation Centers and Industrialization - The Beijing Synthetic Biology Manufacturing Technology Innovation Center, established by the local government and Beijing University of Chemical Technology, serves as a core platform for technological innovation in the synthetic biology industry [4]. - The center focuses on comprehensive technological breakthroughs across the entire biological manufacturing value chain, with five research teams already operational [4][6]. - The shift from traditional petrochemical methods to biological production of materials like adipic acid is highlighted as a key step towards a greener, more sustainable industry, with significant reductions in greenhouse gas emissions [4][5]. Group 3: Industry Growth and Future Prospects - The synthetic biology sector is projected to create an economic value of $30 trillion, with an expected global production scale reaching $2 trillion to $4 trillion by 2030 [7]. - The Changping District has established a cluster of over 120 synthetic biology manufacturing companies, with projected revenues exceeding 6 billion yuan in 2024 and significant investments in fixed assets [8]. - Recent policy measures in Changping aim to support the high-quality development of the synthetic biology industry, emphasizing integrated policies and collaborative efforts across the sector [7][8].